| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/24/2005 | WO2004044138A3 Chimeric oligomeric compounds and their use in gene modulation |
| 03/24/2005 | WO2004044134A3 Phosphorous-linked oligomeric compounds and their use in gene modulation |
| 03/24/2005 | WO2004043979A3 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 03/24/2005 | WO2003104407A3 T cell receptor cdr3 sequences and methods for detection |
| 03/24/2005 | WO2003103478A3 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs |
| 03/24/2005 | WO2003087134A3 G-protein coupled receptor ligands and methods |
| 03/24/2005 | WO2003060151A3 Novel calpastatin (cast) alleles |
| 03/24/2005 | US20050066392 Expression vector comprising nucleotide sequences coding which confer a tolerant phenotype in plants in response to chronic and/or acute inhibitin dosages of auxinic herbicides |
| 03/24/2005 | US20050066380 Perv screening method and use thereof |
| 03/24/2005 | US20050065335 inhibiting complexation of intercalating molecules with polynucleotides; using modified xanthine molecules as a binding agent; drug delivery system for compounds that have low solubility in aqueous media, including anti-neoplastic agents |
| 03/24/2005 | US20050065331 Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides |
| 03/24/2005 | US20050065330 Identification of Histoplasma capsulatum using a PCR assay |
| 03/24/2005 | US20050065106 Plasmid vector comprising nucleotide sequence encoding exterior membrane protein of chlamydia strains; gene expression; veccine |
| 03/24/2005 | US20050064549 Receptor |
| 03/24/2005 | US20050064548 Yeast ectopically expressing abnormally processed proteins and uses therefor |
| 03/24/2005 | US20050064547 Vectors and transfected cells |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064522 EG-VEGF nucleic acids and polypeptides and methods of use |
| 03/24/2005 | US20050064494 Chemically modified biological molecules and methods for coupling biological molecules to solid support |
| 03/24/2005 | US20050064489 Recombinant regulatory sequence for use as tool for controlling heterologous gene expression; genetic engineering and gene therapy; drug screening; RNA interference and gene expression inhibition |
| 03/24/2005 | US20050064487 Using solid support to amplify preferential nucleotide sequences; screening for genetic polymorphisms and aberrations |
| 03/24/2005 | US20050064480 Nucleotide sequences coding formin-like 2 (FHOD-2) gene for use as diagnostic and therapeutic tool in detection and treatment of pancreatic disorders |
| 03/24/2005 | US20050064479 Compounds and methods for post incorporation labeling of nucleic acids |
| 03/24/2005 | US20050064478 Universal nucleic acid amplification system for nucleic acids in a sample |
| 03/24/2005 | US20050064471 Probe design for the detection of RNAs in cell extracts, cells, and tissues |
| 03/24/2005 | US20050064468 concentration, removing or separation of nucleotide bases or nucleotide sequences containing bases from solid supports |
| 03/24/2005 | US20050064463 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders |
| 03/24/2005 | US20050064450 Using unique sequences, polymerase chain reaction and alcohol extraction to generate repetitive sequence removed probes (RSRP) for use in cancer detection |
| 03/24/2005 | US20050064442 Using allelic variation in breast cancer genes (BRAC1/2) as diagnostic tools in diagnosing/prognosing mammary gland cell proliferative disorders |
| 03/24/2005 | US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 03/24/2005 | US20050064431 Biological microarray comprising polymer particles and method of use |
| 03/24/2005 | US20050064426 Utilizing probe dependent coefficients to re-scale and correct hybridization data; enhancing accuracy of measured gene expression levels |
| 03/24/2005 | US20050064420 Expression vector comprising nucleotide sequences coding estrogen response element for use as regulatory tool in heterologous gene expression |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064398 Primers for use in detecting beta-lactamases |
| 03/24/2005 | US20050064392 Expression vector comprising nucleotide sequences coding viral envelope proteins for use as tool in developing genetic vaccines to prevent, block and/or treat viral infection/disease |
| 03/24/2005 | US20050064389 Chimeric lyssavirus nucleic acids and polypeptides |
| 03/24/2005 | US20050063989 Ion channel hybrid proteins as electrical sensors and use thereof |
| 03/24/2005 | US20050063982 GRP94-based compositions and methods of use thereof |
| 03/24/2005 | US20050063946 Human pluripotent hematopoietic colony stimulating factor, method of production and use |
| 03/24/2005 | CA2551022A1 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 03/24/2005 | CA2538883A1 Antisense oligonucleotides for prevention of metastasis formation of cancer cells |
| 03/24/2005 | CA2538514A1 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 03/24/2005 | CA2538222A1 Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms |
| 03/24/2005 | CA2536735A1 Methods for determining cd8+ t-cell epitopes |
| 03/23/2005 | EP1516933A1 Stable hybrids by selecting the position of the probe relative to the target |
| 03/23/2005 | EP1516665A1 A method of immobilizing and stretching a nucleic acid on a substrate |
| 03/23/2005 | EP1515971A2 Carbocyclic nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 03/23/2005 | EP1515601A2 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 03/23/2005 | EP1015642A4 Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 03/23/2005 | EP0804613B1 Dap-2 tumor suppressor gene, protein encoded thereby and use of said gene and protein |
| 03/23/2005 | EP0726905B1 Single nucleotide polymorphisms and their use in genetic analysis |
| 03/23/2005 | EP0674712B1 A proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 03/23/2005 | CN1599746A Adjuvanted meningococcus compositions |
| 03/23/2005 | CN1599627A Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 03/23/2005 | CN1597962A D-Pantothe internal ester hydrolase c DNA and its clone expression and application |
| 03/23/2005 | CN1597957A A group nucleodite sequence of anti-hepatitis virus C infection and preventing and curing hepatitis virus C and its segment and application |
| 03/23/2005 | CN1597951A Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa |
| 03/23/2005 | CN1597931A BCG vaccine strain of recombined interferon and its preparation process |
| 03/23/2005 | CN1597926A Process for enrishing bacteria of producing polyketone kinds compounds |
| 03/23/2005 | CN1597694A Meningococcal antigens |
| 03/23/2005 | CN1597691A Method of improving king crab element gene with higher antibacterial activity and high effect expression |
| 03/23/2005 | CN1194092C Medusa cystatin Protease inhibitor gene, and expression and use therof |
| 03/23/2005 | CN1194091C Coton bollworm molt-regulating transcription factor cDNA and cloning method and recombination application thereof |
| 03/23/2005 | CN1194089C large wasp sedative peptide precursor gene and its coded polypeptide and preparation |
| 03/23/2005 | CN1194016C New human chorionic gonadotropin-lutropin fusion protein and its prepn and use |
| 03/23/2005 | CN1194012C Sperm formation relative protein and its coding sequence and use |
| 03/23/2005 | CN1194010C Human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 03/23/2005 | CN1194003C Small RNA molecule for inhibiting SARS virus infestion |
| 03/23/2005 | CN1194002C Shortened-chain polynucleotide and process for the preparation thereof |
| 03/22/2005 | US6870047 Magnetic pigment |
| 03/22/2005 | US6870046 Antisense modulation of interferon gamma receptor 2 expression |
| 03/22/2005 | US6870045 Kits for detecting HIV-2 |
| 03/22/2005 | US6870039 Synthesizing phosphorothioate oligonucleotides and their intermediates; used in genomic research as probes, primers and alsoin diagnositics |
| 03/22/2005 | US6870037 Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders |
| 03/22/2005 | US6869783 Nucleic acid sequences which code for a polypeptide having nitrilase activity, nucleic acid constructs comprising the nucleic acid sequences, and vectors comprising the nucleic acid sequences or the nucleic constructs |
| 03/22/2005 | US6869769 Utilizes at least one primer for analysis; automatic for massed screening and the discovery of sequence variants of known virons, undetected virons and others |
| 03/22/2005 | US6869764 Nucleic acid sequencing using charge-switch nucleotides |
| 03/22/2005 | US6869762 Crohn's disease-related polymorphisms |
| 03/22/2005 | US6869759 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 03/22/2005 | CA2441850A1 Ion channel hybrid proteins as electrical sensors and use thereof |
| 03/17/2005 | WO2005024386A2 Use of photopolymerization for amplification and detection of a molecular recognition event |
| 03/17/2005 | WO2005024055A1 Methods of diagnosis and prognosis of ovarian cancer ii |
| 03/17/2005 | WO2005024045A2 Primers for use in detecting beta-lactamases |
| 03/17/2005 | WO2005024044A2 Method for the production of fusion proteins in transgenic mammal milk |
| 03/17/2005 | WO2005024043A2 Methods for identifying, diagnosing, and predicting survival of lymphomas |
| 03/17/2005 | WO2005024042A2 Aptamers and methods for their in vitro selection and uses thereof |
| 03/17/2005 | WO2005024039A2 Improved method for generating influenza viruses and vaccines |
| 03/17/2005 | WO2005024030A1 Rodent expression systems utilising polyoma virus and epstein barr virus sequences |
| 03/17/2005 | WO2005024015A1 Expression vector |
| 03/17/2005 | WO2005023995A2 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
| 03/17/2005 | WO2005023994A2 Modified oligonucleotides for telomerase inhibition |
| 03/17/2005 | WO2005023993A2 Methods and compositions for generation of germline human antibody genes |
| 03/17/2005 | WO2005023990A2 Trans-splicing mediated photodynamic therapy |
| 03/17/2005 | WO2005023979A2 Isolated s. mansoni nucleic acid molecules and uses thereof |
| 03/17/2005 | WO2005023865A2 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
| 03/17/2005 | WO2005023829A1 Metal complex type nucleic acid |
| 03/17/2005 | WO2005023828A1 Process for producing ribonucleotide or ribonucleotide derivative |
| 03/17/2005 | WO2005023825A2 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini |
| 03/17/2005 | WO2005023205A2 Compositions and methods for yersinia pestis treatment |